OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Botulinum Toxin in the Treatment of Headache
Werner J. Becker
Toxins (2020) Vol. 12, Iss. 12, pp. 803-803
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study
Licia Grazzi, Riccardo Giossi, Danilo Antonio Montisano, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 10

Glutamatergic systems in neuropathic pain and emerging non-opioid therapies
Rhea Temmermand, James E. Barrett, Andréia C. K. Fontana
Pharmacological Research (2022) Vol. 185, pp. 106492-106492
Open Access | Times Cited: 25

Botulinum Toxin—A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches
Katarzyna Kępczyńska, Izabela Domitrz
Toxins (2022) Vol. 14, Iss. 9, pp. 619-619
Open Access | Times Cited: 23

Early effect of onabotulinumtoxinA on EEG‐based functional connectivity in patients with chronic migraine: A pilot study
Matteo Conti, Roberta Bovenzi, Maria Giuseppina Palmieri, et al.
Headache The Journal of Head and Face Pain (2024) Vol. 64, Iss. 7, pp. 825-837
Open Access | Times Cited: 4

CORONIS symposium 2023: Scientific and clinical frontiers in ocular surface innervation
Anat Galor, Juana Gallar, M. Carmen Acosta, et al.
Acta Ophthalmologica (2025)
Open Access

Botulinum Neurotoxins as Two-Faced Janus Proteins
Silvia Chimienti, Maria Di Spirito, Filippo Molinari, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 411-411
Open Access

Efficacy and Safety of Botulinum Toxin Type A Injection for Trapezius Muscle Contouring: A Systematic Review
Krishan Mohan Kapoor, Anmol Batra, Avneet Kaur, et al.
(2025)
Closed Access

Chronic pelvic pain and botulinum toxin
Barbara I. Karp, Pamela Stratton
Toxicon (2025), pp. 108336-108336
Closed Access

Effects of Botulinum Toxin Type A on the Nociceptive and Lemniscal Somatosensory Systems in Chronic Migraine: An Electrophysiological Study
Gabriele Sebastianelli, Francesco Casillo, Antonio Di Renzo, et al.
Toxins (2023) Vol. 15, Iss. 1, pp. 76-76
Open Access | Times Cited: 10

Relative Pain Reduction and Duration of Nerve Block Response Predict Outcomes in Headache Surgery- A prospective cohort study
Leonard Knoedler, Christian Chartier, Maria E. Casari, et al.
Plastic & Reconstructive Surgery (2023)
Closed Access | Times Cited: 10

Mechanism and clinical use of botulinum neurotoxin in head and facial region
Swarnalakshmi Raman, Yumiko Yamamoto, Yoshitaka Suzuki, et al.
Journal of Prosthodontic Research (2023) Vol. 67, Iss. 4, pp. 493-505
Open Access | Times Cited: 7

Headache frequency and neck pain are associated with trapezius muscle T2 in tension-type headache among young adults
Nico Sollmann, Paul Schandelmaier, Dominik Weidlich, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 7

Selective Expression of a SNARE-Cleaving Protease in Peripheral Sensory Neurons Attenuates Pain-Related Gene Transcription and Neuropeptide Release
Wanzhi Wang, Miaomiao Kong, Yu Dou, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8826-8826
Open Access | Times Cited: 17

Neuromodulation Techniques for Headache Management
Noora Reffat, Carolina M. Pusec, Scott Price, et al.
Life (2024) Vol. 14, Iss. 2, pp. 173-173
Open Access | Times Cited: 2

NGF Enhances CGRP Release Evoked by Capsaicin from Rat Trigeminal Neurons: Differential Inhibition by SNAP-25-Cleaving Proteases
Mariia Belinskaia, Tomas H. Zurawski, Seshu Kumar Kaza, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 892-892
Open Access | Times Cited: 9

Review of Tolerability of Fremanezumab for Episodic and Chronic Migraine
Shane Root, Kevin Ahn, Jack F. Kirsch, et al.
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 391-401
Open Access | Times Cited: 5

The Positive and Negative Predictive Value of Targeted Diagnostic Botox Injection in Nerve Decompression Migraine Surgery
Hassan ElHawary, Kaitlin Kavanagh, Jeffrey E. Janis
Plastic & Reconstructive Surgery (2023)
Closed Access | Times Cited: 5

Botulinum toxin type A (Relatox) in the treatment of chronic migraine in adults: results of phase IIIb, randomized, one-blind, multicenter, active-controlled, parallel-group trial
А. Р. Артеменко, В. Г. Абрамов, З. Н. Коновалова, et al.
S S Korsakov Journal of Neurology and Psychiatry (2023) Vol. 123, Iss. 5, pp. 89-89
Closed Access | Times Cited: 5

Mecanismos de ação e indicações da Toxina Botulínica
Manoel Lesser Francisco Filho, Roberto Teruo Suguihara, Daniella Pilon Muknicka
Research Society and Development (2023) Vol. 12, Iss. 6, pp. e15712642223-e15712642223
Open Access | Times Cited: 5

Comparative Long-Term Effectiveness Of OnabotulinumtoxinA (Botox) And Anti CGRP In Migraine Prevention: A Systematic Review
Elizabeth Gaviria, Awab Hamid Eltayeb Hamid
F1000Research (2024) Vol. 13, pp. 665-665
Open Access | Times Cited: 1

OnabotulinumtoxinA for the treatment of headache: an updated review
Joseph H. Talbet, Ayman G. Elnahry
Journal of Integrative Neuroscience (2022) Vol. 21, Iss. 1, pp. 037-037
Open Access | Times Cited: 7

Novel Treatments for Chronic Ocular Surface Pain
Simran Mangwani‐Mordani, Courtney F. Goodman, Anat Galor
Cornea (2022) Vol. 42, Iss. 3, pp. 261-271
Closed Access | Times Cited: 6

Page 1 - Next Page

Scroll to top